Literature DB >> 1258926

Abnormal coagulation and fibrinolysis in eclampsia. A clinical and laboratory correlation study.

M López-Llera, M de la Luz Espinosa, M Diaz de León, G R Linares.   

Abstract

This study evaluated the existence of abnormally increased coagulation and fibrinolysis in 33 severely toxemic and eclamptic women by means of a combined hemotologic profile with clinical and morphologic correlations. The dominant findings were: different degrees of thrombocytopenia, abnormal levels of blood fibrinogen, prolonged thrombin time, and positive protamine sulfate test. Altered activated partial thromboplastin time and positive ethanol gelation test were slightly less frequent, and only few cases showed prolonged prothrombin time or early lysis of euglobulins. These abnormalities seemed to be more numerous and more pronounced in the worst cases of the series and their severity seemed to be associated with the age of the patient and the presence of previous underlying disease. These variously handicapped pregnant women exhibited worse hematologic hematologic abnormalities, and provided most of the fatal cases in the series. Finally, the main findings were discussed and commented upon.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1258926     DOI: 10.1016/s0002-9378(16)33335-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Laboratory findings in hypertensive disorders of pregnancy.

Authors:  M P FitzGerald; C Floro; J Siegel; E Hernandez
Journal:  J Natl Med Assoc       Date:  1996-12       Impact factor: 1.798

2.  Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis.

Authors:  Maha Othman; Amparo Santamaría Ortiz; María Cerdá; Offer Erez; Adrian Minford; Deborah Obeng-Tuudah; Marc Blondon; Ingrid Bistervels; Saskia Middeldorp; Rezan Abdul-Kadir
Journal:  Res Pract Thromb Haemost       Date:  2019-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.